 OCALA, FL ACCESSWIRE April 29, 2020 AIM ImmunoTech Inc. NYSE American:AIM, an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral diseases and multiple types of cancers, today announced that CEO Thomas K. Equels is scheduled to present 